NS Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.7M Sell
201,301
-4,998
-2% -$391K 0.64% 48
2025
Q1
$15M Buy
206,299
+1,099
+0.5% +$79.7K 0.66% 51
2024
Q4
$15.2M Sell
205,200
-3,441
-2% -$255K 0.63% 52
2024
Q3
$13.8M Buy
208,641
+4,170
+2% +$275K 0.58% 53
2024
Q2
$18.9M Buy
204,471
+756
+0.4% +$69.8K 0.86% 38
2024
Q1
$19.5M Sell
203,715
-4,027
-2% -$385K 0.9% 42
2023
Q4
$15.8M Buy
207,742
+352
+0.2% +$26.8K 0.77% 50
2023
Q3
$14.4M Sell
207,390
-603
-0.3% -$41.8K 0.77% 51
2023
Q2
$19.6M Sell
207,993
-1,531
-0.7% -$144K 1.03% 42
2023
Q1
$17.3M Buy
209,524
+402
+0.2% +$33.3K 0.97% 48
2022
Q4
$15.6M Buy
209,122
+13,334
+7% +$995K 0.94% 51
2022
Q3
$16.2M Sell
195,788
-26,723
-12% -$2.21M 1.05% 43
2022
Q2
$21.2M Buy
222,511
+36,099
+19% +$3.43M 1.28% 31
2022
Q1
$21.9M Sell
186,412
-7,496
-4% -$882K 1.17% 34
2021
Q4
$25.1M Buy
193,908
+618
+0.3% +$80.1K 1.18% 34
2021
Q3
$21.9M Buy
193,290
+861
+0.4% +$97.5K 1.11% 41
2021
Q2
$19.9M Buy
192,429
+722
+0.4% +$74.8K 1.05% 42
2021
Q1
$16M Sell
191,707
-7,802
-4% -$653K 0.93% 44
2020
Q4
$18.2M Buy
199,509
+1,944
+1% +$177K 1.06% 40
2020
Q3
$15.8M Buy
197,565
+7,866
+4% +$628K 1.04% 40
2020
Q2
$13.1M Buy
189,699
+1,014
+0.5% +$70.1K 0.97% 41
2020
Q1
$11.9M Buy
188,685
+57,273
+44% +$3.6M 1.1% 36
2019
Q4
$10.2M Sell
131,412
-33
-0% -$2.57K 0.81% 47
2019
Q3
$9.64M Buy
131,445
+3,786
+3% +$278K 0.87% 47
2019
Q2
$7.86M Buy
127,659
+25,449
+25% +$1.57M 0.72% 52
2019
Q1
$6.52M Hold
102,210
0.6% 60
2018
Q4
$5.22M Buy
102,210
+29,535
+41% +$1.51M 0.56% 63
2018
Q3
$4.22M Buy
+72,675
New +$4.22M 0.4% 77